Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands |
|
|
|
|
12 Months Ended |
|
Aug. 04, 2015 |
Jul. 29, 2015 |
Dec. 01, 2014 |
Jan. 30, 2014 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2016 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
100,000,000
|
|
100,000,000
|
| Common stock, par value |
|
|
|
|
$ 0.001
|
|
$ 0.001
|
| Preferred stock, shares authorized |
|
|
|
|
5,000,000
|
|
5,000,000
|
| Preferred stock, par value |
|
|
|
|
$ 0.001
|
|
$ 0.001
|
| Common stock, shares outstanding |
|
|
|
|
27,254,863
|
|
27,296,863
|
| Preferred stock, shares issued |
|
|
|
|
0
|
|
0
|
| Preferred stock, shares outstanding |
|
|
|
|
0
|
|
0
|
| Common stock, shares issued |
|
|
|
5,750,000
|
|
|
|
| Aggregate gross offering proceeds |
|
|
|
$ 63,250
|
|
|
|
| Net proceeds as a result of IPO |
|
|
|
56,297
|
|
$ 57,762
|
|
| Underwriting discounts and commissions |
|
|
|
$ 6,953
|
|
|
|
| Initial Public Offering [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Public offering price per share |
|
|
|
$ 11.00
|
|
$ 11.00
|
|
| Net proceeds from offering of common stock |
|
|
|
|
|
$ 56,297
|
|
| Initial Public Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
|
|
|
5,750,000
|
|
| Net proceeds from offering of common stock |
|
|
|
|
|
$ 6
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Public offering price per share |
|
|
|
|
|
$ 8.74
|
|
| Net proceeds from offering of common stock |
|
|
|
|
|
$ 100
|
|
| Private Placement [Member] | Chief Medical Officer [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
11,442
|
|
|
|
|
| Public offering price per share |
|
|
$ 8.74
|
|
|
|
|
| Gross proceeds of common stock |
|
|
$ 100
|
|
|
|
|
| Private Placement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
|
|
|
11,442
|
|
| Follow On Public Offering [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Public offering price per share |
|
|
|
|
$ 18.60
|
|
|
| Net proceeds from offering of common stock |
$ 75,231
|
|
|
|
$ 75,231
|
|
|
| Follow On Public Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares issued |
|
3,763,440
|
|
|
4,327,956
|
|
|
| Public offering price per share |
$ 18.60
|
|
|
|
|
|
|
| Net proceeds from offering of common stock |
|
|
|
|
$ 4
|
|
|
| Underwriter's Over-Allotment [Member] | Common Stock [Member] | Maximum [Member] |
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
| Common stock, shares issued |
564,516
|
|
|
|
|
|
|